(2R)-N-[(2S)-3-cyclohexyl-1-[[3-(2-morpholin-4-ylethylamino)-3-oxopropyl]amino]-1-oxopropan-2-yl]-N'-hydroxy-2-[3-(4-methylphenyl)propyl]butanediamide

InChIKey	`DGXRLXMZJHBYOU-IZLXSDGUSA-N`
Compound Name	(2R)-N-[(2S)-3-cyclohexyl-1-[[3-(2-morpholin-4-ylethylamino)-3-oxopropyl]amino]-1-oxopropan-2-yl]-N'-hydroxy-2-[3-(4-methylphenyl)propyl]butanediamide
Canonical SMILES	`Cc1ccc(CCC[C@H](CC(=O)NO)C(=O)N[C@@H](CC2CCCCC2)C(=O)NCCC(=O)NCCN2CCOCC2)cc1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	8.58
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P08253	MMP2	Homo sapiens	Human	PF00040 PF00045 PF00413	11.0	pIC50	TTD_MultiTarget
Q9ULZ9	MMP17	Homo sapiens	Human	PF00045 PF00413 PF01471	8.7	pIC50	TTD_MultiTarget
P08254	MMP3	Homo sapiens	Human	PF00045 PF00413 PF01471	8.2	Ki	ChEMBL;BindingDB
P03956	MMP1	Homo sapiens	Human	PF00045 PF00413 PF01471	6.3	Ki	ChEMBL;BindingDB
P18843	nadE	Escherichia coli (strain K12)	Pathogen	PF02540	8.7	pIC50	TTD_MultiTarget